Cayuga Biotech
cayugabiotech.com
Actively hiring
Transportation & Logistics
Health Care
Biotechnology
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
SOSV
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 3, 2022
New executive Cayuga Biotech Appoints Andrea Ashford-Hicks as Chief Executive Officer · cayugabiotech.com
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
SOSV Similar startupsby what they do, their industry and backers
Innerva Pharmaceuticals is an innovative ophthalmic startup developing novel therapies for ocular surface pain.
Draupnir Bio is developing new innovative therapies for patients.
[AIxBio] intelligence unlocking next therapeutic era. End cancer as a life-threatening disease.
Trotana is developing novel oral anti-inflammatory medicines.
Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
Advancing novel therapies to restore the health of gastrointestinal tissues. Curileum is developing novel therapies that restore the health…
News
Cayuga is Awarded 2026 MTEC Prototype of the Year Award
The post Cayuga is Awarded 2026 MTEC Prototype of the Year Award appeared first on Cayuga Biotech.
Read more
Report
First Subject Dosed in Phase 1 Clinical Trial for CAY001 for Life-Threatening Hemorrhage
The post First Subject Dosed in Phase 1 Clinical Trial for CAY001 for Life-Threatening Hemorrhage appeared first on Cayuga Biotech.
Read more
Report
Full Data on Cayuga's Novel Synthetic Compound in Stopping Life-Threatening Hemorrhage Shows Promise
The post Full Data on Cayuga's Novel Synthetic Compound in Stopping Life-Threatening Hemorrhage Shows Promise appeared first on Cayuga Biotech.
Read more
Report
Cayuga's CAY001 Significantly Increases Survival and Improves Bleeding Outcomes in Platelet Inhibitor-Related Bleeding
The post Cayuga's CAY001 Significantly Increases Survival and Improves Bleeding Outcomes in Platelet Inhibitor-Related Bleeding appeared first on Cayuga Biotech.
Read more
Report
Pro access
Upgrade to see all 20 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.